ATE283057T1 - Austausch von t-lymphozyten - Google Patents

Austausch von t-lymphozyten

Info

Publication number
ATE283057T1
ATE283057T1 AT99401724T AT99401724T ATE283057T1 AT E283057 T1 ATE283057 T1 AT E283057T1 AT 99401724 T AT99401724 T AT 99401724T AT 99401724 T AT99401724 T AT 99401724T AT E283057 T1 ATE283057 T1 AT E283057T1
Authority
AT
Austria
Prior art keywords
lymphocytes
composition
exchange
population
subject
Prior art date
Application number
AT99401724T
Other languages
English (en)
Inventor
David Klatzmann
Jose Cohen
Olivier Boyer
Veronique Thomas-Vaslin
Jean-Loup Salzmann
Original Assignee
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris Curie filed Critical Univ Paris Curie
Application granted granted Critical
Publication of ATE283057T1 publication Critical patent/ATE283057T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99401724T 1998-07-10 1999-07-08 Austausch von t-lymphozyten ATE283057T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9808952A FR2780891A1 (fr) 1998-07-10 1998-07-10 Echange de lymphocytes t

Publications (1)

Publication Number Publication Date
ATE283057T1 true ATE283057T1 (de) 2004-12-15

Family

ID=9528575

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99401724T ATE283057T1 (de) 1998-07-10 1999-07-08 Austausch von t-lymphozyten

Country Status (7)

Country Link
EP (1) EP0972518B1 (de)
JP (1) JP2002520262A (de)
AT (1) ATE283057T1 (de)
DE (1) DE69922090T2 (de)
ES (1) ES2234220T3 (de)
FR (1) FR2780891A1 (de)
WO (1) WO2000002520A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867041B2 (en) 2000-02-24 2005-03-15 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
EP1294699B1 (de) 2000-05-12 2016-04-13 Genzyme Corporation Modulatoren des tnf-alpha-signalweges
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
ES2559763T3 (es) 2002-09-10 2016-02-15 Affimed Gmbh Anticuerpo humano específico de CD3 con propiedades inmunosupresoras
ATE481476T1 (de) 2003-05-08 2010-10-15 Life Technologies Corp Erzeugung und isolierung antigenspezifischer t- zellen
EP2217698B1 (de) * 2007-10-12 2013-03-06 Université Pierre et Marie Curie (Paris 6) Verfahren für optimierte blutzellentransplantation
US20100215629A1 (en) * 2007-10-12 2010-08-26 Universite Pierre Et Marie Curie (Paris 6) Treatment of tumors using t lymphocyte preparations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06298654A (ja) * 1993-04-12 1994-10-25 Sumitomo Electric Ind Ltd 抗原特異的免疫抑制剤
US5595881A (en) * 1994-08-09 1997-01-21 Anergen, Inc. Method for the detection of antigen presenting cells
ATE244305T1 (de) * 1995-05-04 2003-07-15 Us Gov Sec Navy Verfahren zur modulation der t-zell- überlebensrate durch von bcl-xl protein-spiegels
IL127211A0 (en) * 1996-05-31 1999-09-22 Genetic Therapy Inc Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers

Also Published As

Publication number Publication date
DE69922090T2 (de) 2005-12-01
EP0972518A2 (de) 2000-01-19
WO2000002520A2 (fr) 2000-01-20
DE69922090D1 (de) 2004-12-30
FR2780891A1 (fr) 2000-01-14
ES2234220T3 (es) 2005-06-16
EP0972518B1 (de) 2004-11-24
JP2002520262A (ja) 2002-07-09
WO2000002520A3 (fr) 2000-03-23
EP0972518A3 (de) 2000-01-26

Similar Documents

Publication Publication Date Title
FR2621245B1 (fr) Table d'operation orthopedique pour membres et notamment pour membres inferieurs
FR2668063B1 (de)
NZ222977A (en) Aminotetralins and pharmaceutical compositions; 8-substituted-2-aminotetralins and pharmaceutical compositions thereof
FR2628317B1 (fr) Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
DE3777763D1 (de) Dimethylpolysiloxan-mikroemulsionen enthaltende kosmetische zusammensetzungen.
PT84182B (pt) Novo retrovirus susceptivel de provocar o sida, meios e processos para a sua deteccao "in vitro"
JPS6471889A (en) Novel 6-acyl-(6h)-dibenzo(c,e)(1,2)oxaphosphorine- 6-oxide, manufacture and use as photoinitiator
EP0243616A3 (en) Liquid preparations of 1,2-benzisothiazol-in-3-one
ATE283057T1 (de) Austausch von t-lymphozyten
IT8722064A0 (it) Dispositivo per la separazione di impurita', come rifiuti, pelature e simili per una carda.
IT8883551A0 (it) Procedimento per l'estrazione e la purificazione di dna
FR2598312B1 (fr) Aerateur sinusien permanent trans-nasal en double " t "
HUT43829A (en) Process for producing 1,1-disubstituted cyclopropan derivatives and pharmaceutical and/or fungicide compositions containing them as active agents
FR2606677B1 (fr) Applicateur de liquide, par exemple applicateur de produit de beaute, instrument d'ecriture, etc.
FR2580494B1 (fr) Composition cosmetique pour le traitement des cheveux, notamment des cheveux gras a base d'un extrait de millefeuille (achillea millefolium l)
PT82554A (en) Process for the preparation of (2,4,5-cis)dioxane and compositions therewith
NZ219719A (en) Endo-4-amino-5-chloro-2-methoxy-n-cl-azabicyclo -(3,3,1)-non-4-yl)-benzamide and pharmaceutical compositions
EP0317913A3 (en) Di(meth)acrylates, process for their preparation and their use
IT8721945A0 (it) Procedimento per la profumazione di libri, dispositivo per l'attuazione di detto procedimento
FR2763596B1 (fr) Produits stabilisants, compositions et concentres les contenant, et leur procede d'utilisation
IL79249A0 (en) Herbicidal compositions containing haloalkylthioquinazoline di(thi)ones,and some new such compounds
FR2654123B1 (fr) Solution d'agent de blanchiment fluorescent.
IT8820978A0 (it) Composizione erbicida conselettivita' aumentata e processo per la preparazione di entrambi i componenti ingredienti attivi in un solo stadio.
IT8720208A0 (it) Macchina per l'impiego forestale destinata in particolare per la lavorazione di alberi.
Yoshihashi Interaction Design

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties